AI Agents for Podiatry Practices: Automating Billing From Routine Foot Care to Reconstructive Surgery in 2026

No specialty in medicine has a single billing classification question that generates more denials, audits, and compliance risk than podiatry's routine-vs-medical foot care determination. Every nail debridement, every callus reduction, every corn removal requires a binary decision — is this service medically necessary because of a qualifying systemic condition, or is it routine care that Medicare doesn't cover? Get it right, and the encounter pays. Get it wrong in either direction, and the practice either loses the revenue or triggers a Medicare audit that can recoup years of payments.

That classification question is just the entry point. Podiatry billing spans diabetic foot care programs that most practices leave entirely unbilled, wound care encounters that generate 4–6 line items when captured correctly, surgical procedures with 90-day global periods and bilateral modifier complexity, and an in-office procedure volume — from matrixectomies to injections to custom orthotics — that creates dozens of charge capture opportunities per day.

The 2026 environment makes podiatry billing harder. Medicare's Recovery Audit Contractors continue to target routine foot care as one of their highest-recovery service categories — meaning every Q-modifier error is a recoupment waiting to happen. The 30–40% annual billing staff turnover (HFMA 2026) hits podiatry disproportionately because the routine-vs-medical classification rules require specialty-specific training that generic billers don't have. And the growing diabetic population — over 37 million Americans with diabetes and 96 million with prediabetes — means the volume of encounters requiring correct classification is increasing faster than practices can train staff to handle them.

AI agents automate every revenue category in podiatry billing — from the qualifying-condition classification that determines whether a nail debridement is billable at all, to the wound care CTP coding that captures $300–$500 per encounter that manual teams consistently miss.

Routine vs Medical Foot Care: The Classification That Drives Every Podiatry Audit

Medicare covers foot care — nail debridement, callus trimming, corn removal — only when the patient has a documented systemic condition that makes self-care hazardous. Without a qualifying diagnosis, these services are classified as routine foot care and excluded from coverage. The classification depends on two tiers of clinical findings.

Class A and Class B Findings: The Qualifying Criteria

Medicare defines the qualifying conditions that convert routine foot care to covered medical services:

The billing codes for nail care are straightforward — 11720 (debridement of 1–5 nails) and 11721 (debridement of 6 or more nails). But the Q-modifier selection determines whether Medicare pays the claim at all. A nail debridement billed with -Q7 tells Medicare the patient has one Class A finding (usually peripheral neuropathy). Billed without a Q-modifier, the same service is routine and denied.

The errors run in both directions. Practices that bill every nail debridement as medical with -Q7/-Q8/-Q9 without verifying that the qualifying condition is documented in the current encounter note trigger audit exposure. Medicare RACs know that routine foot care with Q-modifiers is one of the highest-recovery audit categories in podiatry — and when they find systematic overbilling, they extrapolate the error rate across the entire look-back period. A 20% error rate on 3,000 annual nail debridements at $50 per encounter, extrapolated across 4 years, produces a six-figure recoupment demand.

Conversely, practices that default to billing nail debridements as routine — either because the biller isn't trained on Q-modifier rules or because the provider doesn't document the systemic condition in each encounter — lose $30–$60 per encounter on every qualifying patient. For a practice seeing 2,000–5,000 Medicare foot care patients annually with 60–80% qualifying for medical coverage, that default costs $40K–$100K in legitimate revenue.

AI agents scan each patient's active problem list and the current encounter note for Class A findings (ICD-10 codes E11.42/E11.51/I73.9/Z89.x and corresponding clinical documentation) and Class B trophic changes. When a qualifying condition is documented, AI applies the correct Q-modifier based on the number of findings. When documentation is incomplete, AI flags the encounter for provider review before submission — not after denial. When no qualifying condition exists, AI routes the encounter to the patient-pay workflow with an automatic ABN (Advance Beneficiary Notice) generation.

Callus and Corn Management: Same Rules, Different Codes

Callus paring (11055 — single lesion, 11056 — 2–4 lesions, 11057 — more than 4 lesions) follows the identical routine-vs-medical classification. Without a qualifying systemic condition and correct Q-modifier, these services are denied. The additional complexity: many encounters include both nail debridement and callus paring on the same visit, requiring modifier -25 on the E/M when a separately identifiable evaluation is performed, and modifier -59/-XS when multiple lesion management codes are billed together.

AI agents count the number of distinct lesions treated per encounter, select the correct callus code (11055/11056/11057), ensure Q-modifiers are applied consistently across all foot care codes on the same claim, and validate modifier -59/-XS when nail debridement and callus paring are billed as distinct services.

A four-podiatrist practice that correctly classifies and modifies every nail debridement and callus encounter — instead of defaulting to routine — recovers an average of $65K more per year than practices that leave the Q-modifier decision to each biller's judgment.

Diabetic Foot Care Programs: The Revenue Stream Most Practices Never Bill

Medicare covers a comprehensive diabetic foot care program for patients with diabetes and documented loss of protective sensation (LOPS). The program includes an annual comprehensive foot exam, routine foot care visits for qualifying patients, and the therapeutic shoe program. Most podiatry practices perform all three clinical services — and bill for none of the program-specific codes.

The Comprehensive Diabetic Foot Exam

Medicare covers one comprehensive foot examination per calendar year for patients with diabetic sensory neuropathy and LOPS:

• G0245 — Initial foot examination for a patient newly diagnosed with diabetic sensory neuropathy and LOPS: ~$75
• G0246 — Follow-up evaluation of the diabetic foot: ~$45

The exam requires documented testing with a 5.07/10-gram Semmes-Weinstein monofilament at specific plantar sites (typically 4–10 sites per foot) plus at least one additional sensory test — vibration perception threshold, ankle reflexes, or pinprick testing. When the exam confirms LOPS, it qualifies the patient for both covered routine foot care (with Q-modifiers) and the therapeutic shoe program.

The billing error: podiatrists perform the monofilament testing during a standard office visit, document the findings, and bill only the E/M code — never submitting G0245 or G0246. For a practice with 800–2,000 diabetic patients, missing the annual comprehensive foot exam charge costs $36K–$90K in unbilled services.

The Therapeutic Shoe Program

Medicare's diabetic therapeutic shoe program covers one pair of depth-inlay shoes (A5500) or custom-molded shoes (A5501) plus up to three pairs of multi-density inserts (A5512/A5513) per calendar year for qualifying diabetic patients. The program requires:

• A certifying physician statement from the treating physician (MD/DO managing the diabetes — not the podiatrist)
• A prescription from the podiatrist specifying the footwear
• Documentation that the patient was fitted and received the shoes

The revenue per qualifying patient is significant — $150–$300 for shoes plus inserts per calendar year. But the program requires coordination between the certifying physician and the podiatrist, and most practices either don't have a workflow for obtaining the certifying statement or don't track which patients are eligible for annual renewal.

AI agents identify every patient with diabetes and documented LOPS, flag those eligible for the therapeutic shoe program, track whether the certifying physician statement has been obtained, and alert the practice when a patient's annual eligibility renews. For a practice with 500–1,500 eligible diabetic patients where even 30–50% participate in the shoe program, systematic program management generates $25K–$75K in annual revenue from shoes and inserts alone — a revenue stream that requires zero additional clinical time.

Surgical Coding: Global Periods, Bilateral Modifiers, and Multi-Procedure Bundling

Podiatric surgery spans a wide range of procedures from in-office matrixectomies to OR-based reconstructive bunionectomies, each with distinct global period rules, modifier requirements, and bundling edits.

Bunionectomy: Five Codes, Five Different Operations

Bunionectomy coding depends on the surgical technique, and each technique carries a 90-day global period:

The coding error that costs podiatry practices the most: billing the wrong bunionectomy code for the procedure actually performed. A Lapidus procedure (28299) billed as a Chevron (28296) underpays by $200. An Akin osteotomy (28298) performed as a concomitant procedure with a Chevron bunionectomy is separately billable with modifier -51 — but billers who don't recognize it as a distinct procedure leave $750 unbilled.

Bilateral bunionectomy adds modifier complexity. Some payers accept -50 (bilateral procedure) at 150% of the unilateral rate. Others require -RT/-LT with separate claims for each side. And staged bilateral procedures — where the second foot is done 4–8 weeks after the first — require modifier -58 (staged procedure during the global period of the first surgery) to avoid denial.

Hammertoe, Neuroma, and Concomitant Procedures

Podiatric surgery frequently involves multiple procedures on the same foot in the same operative session:

• 28285 — Hammertoe correction (PIP arthroplasty), single toe: ~$650
• 28080 — Excision of interdigital neuroma (Morton's neuroma): ~$750
• 28008 — Fasciotomy, plantar fascia, open: ~$500
• 28120 — Partial excision of bone (calcaneal spur): ~$550

When a patient undergoes bunionectomy (28296) plus hammertoe correction on the second toe (28285) plus hammertoe on the third toe (28285-59) in the same session, the encounter generates three separately billable procedures — but only when the modifier cascade is correct. The primary procedure (28296) is billed at 100%. The second procedure (28285) receives modifier -51 (multiple procedures) and is typically reimbursed at 50% of the full rate. The third procedure (28285-59 or 28285-XS for a distinct anatomic site) must have the distinct-procedure modifier to prevent CCI bundling denial. Billers who submit only the primary bunionectomy and forget the concomitant hammertoe corrections leave $400–$700 per case unbilled.

AI agents map every documented procedure from the operative report, assign the correct primary procedure, apply -51 to secondary procedures, add -59/-XS for distinct anatomic sites, select -50 vs -RT/-LT based on the specific payer's bilateral policy, and track the 90-day global period across every active surgical patient. When a patient returns during the global period for a related complication, AI applies -78 (unplanned return for a related procedure); when the return is for an unrelated problem, AI applies -79. For practices performing 300–800 surgical cases annually, correct multi-procedure and modifier coding recovers $30K–$80K.

Wound Care: Debridement and CTP Billing That Generates $300–$500 Per Encounter

Chronic wound management — primarily diabetic foot ulcers — is one of the highest-reimbursement service lines in podiatry. A single wound care encounter that includes selective debridement and CTP (cellular tissue-based product) application generates $300–$500 in combined charges. But capturing the full charge set requires precise documentation and multi-code billing that most manual teams underperform.

Selective Debridement: Size-Based Coding

Selective wound debridement uses size-based coding:

• 97597 — Debridement, open wound, selective, first 20 sq cm: ~$100
• 97598 — Each additional 20 sq cm (add-on to 97597): ~$45

A 35 sq cm diabetic foot ulcer undergoing sharp debridement generates 97597 (first 20 sq cm) plus one unit of 97598 (remaining 15 sq cm rounds up to the next unit). The charge: ~$145. A 60 sq cm wound generates 97597 plus two units of 97598: ~$190. The billing errors: billers who submit only 97597 regardless of wound size, billers who don't measure or document the wound dimensions, and billers who code selective debridement as a non-billable wound care service.

CTP Application: The Dual-Charge Structure

When a skin substitute or cellular tissue-based product is applied to a wound after debridement, two separate charges are generated:

1. Application codes — 15275 (skin substitute graft to feet, first 25 sq cm) and 15276 (each additional 25 sq cm): $200–$350 combined
2. Product supply codes — Q-codes specific to each CTP product (Q4101 Apligraf, Q4121 TheraSkin, Q4131 Grafix, Q4196 EpiFix, and dozens of others): $50–$300+ per application depending on the product and graft size

A wound care encounter with selective debridement of a 30 sq cm ulcer followed by CTP application generates: 97597 + 97598 (debridement, ~$145) + 15275 + 15276 (application, ~$275) + Q-code (product supply, ~$100–$300) = $520–$720 total. Practices that bill only the debridement and skip the CTP application and product charges leave 60–70% of the encounter revenue unbilled.

CTP billing also carries frequency limits that vary by payer and product category. Medicare typically limits CTP application to once per wound per week for the first month, then every other week, with a maximum total number of applications per wound episode. AI agents track each wound's CTP application history against the payer-specific frequency schedule, ensure wound measurements are documented at each visit to support continued medical necessity, and alert the provider when a wound is approaching the application limit — preventing both missed charges and retroactive recoupment from over-application.

AI agents capture the complete wound care charge set for every encounter — debridement with correct size-based units, CTP application codes matched to the anatomic site (15275/15276 for feet), product supply Q-codes, and modifier -59/-XS to separate debridement from application when both are performed. For practices managing 100–400 active wound care patients across 1,000–4,000 annual wound encounters, correct wound care billing generates $20K–$60K above what manual billing captures.

In-Office Procedures: The Daily Revenue Most Practices Underbill

Podiatry practices perform 10–30 in-office procedures per day that each generate one or more billable charges. The cumulative revenue from correct in-office billing often exceeds surgical revenue — but only when every procedure is captured.

Matrixectomy: Three Levels, One Missed Code

Ingrown toenail procedures follow a three-tier coding structure:

• 11730 — Avulsion of nail plate, partial or complete, simple, single: ~$95
• 11732 — Each additional nail plate (add-on to 11730): ~$55
• 11750 — Excision of nail and nail matrix, partial or complete, permanent removal (chemical or surgical matrixectomy): ~$240

A chemical matrixectomy with phenol application is a permanent nail removal (11750), not a simple avulsion (11730). But billers who don't distinguish between temporary avulsion and permanent matrixectomy default to 11730 — underbilling by $145 per procedure. For a practice performing 200–600 matrixectomies annually, that coding default costs $20K–$60K.

When a matrixectomy is performed bilaterally (same toe, both borders) or on multiple toes in the same session, the add-on codes and bilateral modifiers add $55–$145 per additional nail. AI agents read the procedure note for the specific technique performed (avulsion vs chemical vs surgical matrixectomy), determine permanence based on the documentation, and select the correct code with appropriate add-on and laterality modifiers.

Injection Coding and Drug Supply Capture

Podiatric injections span three joint-size tiers plus tendon and ligament injections:

Every injection also generates a drug supply charge — corticosteroid (J1030 methylprednisolone, J1040 methylprednisolone 80mg, J3301 triamcinolone), local anesthetic, or hyaluronic acid for applicable joint injections. The drug J-code is separately billable from the injection procedure. Billers who submit only the injection code without the drug supply J-code leave $15–$40 per injection unbilled. Across 500–2,000 annual injections, missing drug supply charges costs $10K–$40K.

Ultrasound-guided injections add a separately billable imaging charge (76942) when the podiatrist uses ultrasound for needle guidance and stores diagnostic-quality images. Plantar fascia injections and ankle joint injections are increasingly performed under ultrasound guidance — and the imaging charge ($60–$80) nearly doubles the encounter reimbursement compared to landmark-guided injection alone.

Custom Orthotics: Casting, Fabrication, and Fitting

Custom orthotic fabrication generates revenue at multiple stages:

• Biomechanical examination (included in E/M or separately billed gait analysis)
• Casting/impression — foam impression box, plaster casting, or 3D scanning
• L-codes for the device — L3000-L3030 (foot inserts), L3040-L3100 (arch supports), L3201-L3265 (orthopedic shoes and modifications)
• Fitting and delivery

Medicare coverage for custom orthotics requires a qualifying diagnosis (plantar fasciitis, pes planus, diabetic neuropathy with ulcer risk) and documentation that over-the-counter inserts have failed. Commercial payers vary widely — some cover orthotics under the medical benefit with prior authorization, others exclude them entirely, and others cover them under a separate DME benefit with different cost-sharing.

AI agents verify each patient's orthotic benefit coverage, route claims to the correct benefit (medical vs DME), apply the appropriate L-codes based on the device specification and prescription, and track the replacement timeline (Medicare typically covers one pair every 2 years for non-diabetic patients, more frequently for diabetic patients with documented wear). For practices dispensing 300–800 custom orthotics annually, correct coding, benefit routing, and replacement tracking generates $30K–$80K in revenue that practices with inconsistent DME billing leave on the table.

What AI Billing Automation Looks Like in a Podiatry Practice

AI agents for podiatry practices integrate with the practice's EHR and PM system (ModMed Podiatry, NextGen, athenahealth, DrChrono, or specialty platforms like NexTech) and run continuously across every encounter:

1. Per foot care encounter: AI scans the problem list and current visit documentation for Class A/B findings, applies the correct Q-modifier (-Q7/-Q8/-Q9) when qualifying conditions are documented, and routes non-qualifying encounters to patient-pay with ABN generation
2. Per wound care encounter: AI captures wound measurements, generates size-based debridement codes (97597/97598), adds CTP application and product supply codes when skin substitutes are applied, tracks per-wound application frequency against payer limits, and validates that debridement and application are billed as distinct services
3. Per surgical encounter: AI maps every documented procedure from the operative report, selects the correct primary code, applies -51/-59/-XS for concomitant procedures, determines -50 vs -RT/-LT based on payer bilateral policy, and initiates 90-day global period tracking
4. Per injection encounter: AI selects the correct joint-size tier, captures drug supply J-codes, adds ultrasound guidance 76942 when documented, and validates modifier -25 when a separately identifiable E/M occurs
5. Monthly: AI scans the diabetic patient panel for G0245/G0246 exam eligibility, flags patients due for therapeutic shoe program renewal, and identifies patients with LOPS documentation who aren't receiving covered routine foot care
6. Quarterly: AI audits Q-modifier accuracy against documented diagnoses, reconciles CTP application counts against payer limits, and produces a wound care utilization report

Deployment takes 3–6 weeks. The first phase connects to the EHR and PM system, maps the patient panel by diagnosis (diabetic, PVD, neuropathy), and runs a retrospective audit of the prior 90 days to quantify current revenue leakage. Most practices see the first measurable impact — corrected Q-modifier application and captured drug supply codes — within 30 days.

The Financial Case: What Podiatry Practices Recover

For a practice with 2–6 podiatrists managing 5,000–15,000 active patients (including 1,000–3,000 diabetic patients, 100–400 wound care patients, and 300–800 surgical cases), the annual revenue recovery from AI billing automation breaks down:

The ROI calculation is direct. AI billing automation costs a fraction of the salary for one podiatry-trained biller ($45K–$60K plus benefits) and eliminates the specialty-specific training gap that makes podiatry billing staff difficult to recruit. The routine-vs-medical foot care classification alone — the single question that generates more podiatry denials than all other categories combined — moves from a per-encounter human judgment call to an automated, auditable decision based on documented diagnoses. Practices that automate this classification see their Medicare denial rate for foot care services drop from 15–20% to under 3% within 60 days. Most practices reach full ROI within the first quarter.